Related Articles
Therapeutic management of atypical antipsychotic‑related metabolic dysfunctions using GLP‑1 receptor agonists: A systematic review
Affective disorders: A question of continuing treatment during pregnancy (Review)
SOCS3 and SOCS6 are required for the risperidone-mediated inhibition of insulin and leptin signaling in neuroblastoma cells
Gaps or links between hormonal therapy and schizophrenia? (Review)
Current advances in metabolomic studies on non‑motor psychiatric manifestations of Parkinson's disease (Review)